ArticleInvestigative ophthalmology & visual science2025
Polygenic Risk Prediction for Normal-Tension Glaucoma.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Combining structural and microvascular parameters via machine learning for enhanced diagnosis of normal-tension glaucoma among highly myopic eyes: a prospective cross-sectional diagnostic accuracy study.BMC ophthalmology · 2026Article
- A deep ensemble encoder network method for improved polygenic risk score prediction.BioData mining · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Purpose: Normal-tension glaucoma (NTG) is a subtype of glaucoma characterized by optic nerve damage in the setting of normal intraocular pressure. Polygenic risk scores (PRSs) have shown potential to assist with risk prediction in glaucoma, but to date no comprehensive studies have evaluated the predictive ability of PRSs for NTG. Methods: We utilized genome-wide association study (GWAS) summary data for NTG from a European cohort to estimate the variant weights and construct PRSs. The PRSs were computed using both the SBayesRC and clumping and thresholding (C+T) methods in 317 European ancestry NTG cases and 634 controls from the National Institutes of Health All of Us dataset. To validate our findings, we used the Genetics of Glaucoma (GOG) dataset for NTG cases (n = 89) and the QSkin Sun and Health Study (QSkin) dataset for controls (n = 267). Results: We applied the SBayesRC method, which incorporates genome functional annotation, to compare results across both studies. Logistic regression was performed to assess the association between PRSs and NTG. SBayesRC analysis demonstrated that the NTG PRS was significantly associated with NTG, yielding an odds ratio per standard deviation of 1.53 (95% confidence interval [CI], 1.32-1.77; P = 6.86 × 10⁻9) in the All of Us dataset and 1.83 (95% CI, 1.42-2.38; P = 4.01 × 10⁻6) in the combined GOG and QSkin dataset. The C+T method produced results similar to those for SBayesRC. Conclusions: Despite the limited sample size of current NTG GWASs, our findings suggest that NTG-specific PRSs hold promise for risk prediction. Future large-scale GWASs for NTG may enable the development of clinically relevant PRSs, improving early detection and personalized risk assessment for this challenging phenotype.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.